VIDEO: ETF of the Week: XMMO

VettaFi’s Todd Rosenbluth highlighted the Invesco S&P MidCap Momentum ETF (XMMO), a semi‑annually rebalanced, relative‑strength strategy that holds roughly 80 names (the top ~20% of the S&P MidCap 400 by six‑month momentum) and has been a recent outperformer — up about 11% through the first ten months of the year and showing roughly 16% versus 13% for the S&P MidCap 400 on a multi‑year basis, placing it near the top of its Morningstar peer group. The portfolio is concentrated in industrials and technology (about half of assets) and underweights financials, healthcare, real estate, energy and materials, which explains both its upside in recent mid‑cap leadership and the risk that it will lag if sector leadership rotates before the next rebalance. Rosenbluth said XMMO can serve either as a core mid‑cap sleeve for investors comfortable with a risk‑on, momentum bias or as a complement to a broader, more diversified mid‑cap allocation, but warned that momentum strategies are vulnerable when trends reverse.

Analysis

The Invesco S&P MidCap Momentum ETF (XMMO) is a semi‑annually rebalanced, relative‑strength strategy that holds roughly 80 names (the top ~20% of the S&P MidCap 400 by six‑month momentum) and last rebalanced at the end of September. Performance has been a tailwind: XMMO was up about 11% through the first ten months of the year and the ETF and its index are roughly +16% versus +13% for the S&P MidCap 400 on a multi‑year basis, placing it near the top of its Morningstar peer group over 10–15 year horizons.

The portfolio is sector‑concentrated, with industrials representing roughly one‑third of assets and industrials plus technology accounting for about half the fund, while financials are only ~10% and healthcare, real estate, energy and materials are materially underweighted. Relative‑strength selection and the six‑month rebalance drive that concentration versus a plain‑vanilla midcap exposure (MDY is a convenient reference).

Implications for investors are mixed: the strategy can serve as a core midcap sleeve for those willing to accept a risk‑on, momentum‑tilted bias or as a tactical complement to a broader midcap allocation, but it is vulnerable to sector leadership rotation before the next rebalance (next scheduled window in March). Signal outputs are mildly positive with modest market impact, so flows and momentum may sustain current outperformance but should be monitored closely against sector leadership and momentum deterioration.

Key Decisions for Investors

• Consider XMMO as a core midcap sleeve only if you accept a risk‑on, momentum bias and are comfortable with sector concentration in industrials and technology
• Use XMMO tactically as a complement to a diversified midcap holding rather than replacing all midcap exposure, or cap allocation size to limit concentration risk
• Monitor six‑month relative strength, sector leadership (watch for rotation into healthcare, energy, materials, or real estate), and the March rebalance as triggers to trim, hedge, or reallocate exposure